New combination for brain cancer.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D015774:Ganciclovir / Q000008:administration & dosage; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D015215:Zidovudine / Q000008:administration & dosage
D007376:Interleukin-2; D015215:Zidovudine; D015774:Ganciclovir